Survey 2006 2013 P   N=416 % N=342 % Modalities of HCV treatment Never treated 164 42 130 38 0.71 Previously treated or ongoing treatment 227  58 210 62 0.07 Unknown 25  - 2 - < 0.001 Modalities of the last HCV treatment Peg-IFN plus ribavirin 167 80 161 88 0.056 Peg-IFN plus ribavirin plus boceprevir - - 11 6 . Peg-IFN plus ribavirin plus telaprevir - - 12 6 . Virological response to HCV treatment Sustained virological response 50 30 80 50 < 0.001 Non virological response 73 44 49 31 0.016 Virological relapse/breakthrough 44 26 30 19 0.11 Missing - - 34 - . Anti-depressant use 77 20 8 2 < 0.001 Erythropoietin use 27 7 16 5 0.34

Table 3: Modalities and virological results of HCV treatment in HIV-HCV co-infected patients in the 2006 and 2013 surveys.

Goto home»